Flu vaccine maker Seqirus has successfully opposed Moderna’s proposed patent for a mRNA vaccine, but an IP Australia delegate said the problems with the patent can be overcome by amendments.
For information on rights and reprints, contact subscriptions@lawyerly.com.au